Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Fenoprofen. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 known ✓ | P23219 | 5/20 | 0.97 |
| ▸ | PTGS2 known ✓ | P35354 | 5/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.57 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fenoprofen SCHEMBL8706502 | 1.00 | PTGS1 (0.97) | PTGS1MEN1CYP2D6KMT2AALOX5 | |
| Fenoprofen SCHEMBL6269014 | 0.98 | PTGS1 (0.94) | PTGS1MEN1CYP2D6KMT2AALOX5 | |
| Fenoprofen SCHEMBL435081 | 0.98 | PTGS1 (0.94) | PTGS1MEN1CYP2D6KMT2AALOX5 | |
| Fenoprofen SCHEMBL5108677 | 0.98 | PTGS1 (0.94) | PTGS1MEN1CYP2D6KMT2AALOX5 | |
| Fenoprofen SCHEMBL11336376 | 0.98 | PTGS1 (1.00) | PTGS1MEN1CYP2D6KMT2AALOX5 | |
| Fenoprofen SCHEMBL3797 | 0.98 | PTGS1 (1.00) | PTGS1MEN1CYP2D6KMT2AALOX5 | |
| Fenoprofen SCHEMBL8754928 | 0.98 | PTGS1 (1.00) | PTGS1MEN1CYP2D6KMT2AALOX5 | |
| R-Fenoprofen SCHEMBL4082 | 0.98 | PTGS1 (1.00) | PTGS1MEN1CYP2D6KMT2AALOX5 | |
| (S)-Fenoprofen SCHEMBL4492279 | 0.98 | PTGS1 (1.00) | PTGS1MEN1CYP2D6KMT2AALOX5 | |
| R-Fenoprofen SCHEMBL30910976 | 0.98 | PTGS1 (1.00) | PTGS1MEN1CYP2D6KMT2AALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5955 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4701663-A1 | PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS, COMBINATIONS AND USES THEREOF | Insilico Medicine IP Limited (HK) | 2026-03-04 | — | — | EP | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| WO-2025132620-A1 | STABLE SOFT CAPSULE PREPARATIONS WITH SOLID FILL FOR MOISTURE SENSITIVE ACTIVE INGREDIENTS | BAYER CONSUMER CARE AG (CH) | 2025-06-26 | — | — | WO | claimed |
| CN-119757554-A | High performance liquid chromatography-tandem mass spectrometry analysis method for simultaneously detecting 33 components of anti-inflammatory agent in cosmetics | 四川省药品检验研究院(四川省医疗器械检测中心) | 2025-04-04 | — | — | CN | claimed |
| US-20250099590-A1 | HIGH DENSITY ULTRASOUND COUPLING GEL AND METHODS OF USE THEREOF | ZETROZ SYSTEMS LLC (US) | 2025-03-27 | — | — | US | claimed |
| CN-119591490-A | Preparation method of fenoprofen and preparation method of fenoprofen calcium | 康普药业股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| WO-2024222890-A1 | PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS, COMBINATIONS AND USES THEREOF | INSILICO MEDICINE IP LIMITED (CN) | 2024-10-31 | — | — | WO | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| CN-118267481-A | Construction and application of mRNA nano delivery system with environment adaptability and cooperative regulation | 浙江大学 | 2024-07-02 | — | — | CN | claimed |
| EP-0225005-B1 | ANTI-INFLAMMATORY ANALGESIC ADHESIVE PREPARATION | NITTO DENKO CORPORATION (JP) | 1990-03-14 | — | — | EP | claimed |
| EP-0271489-B1 | THERAPEUTIC COMPOSITION | BLASS, David Henry (GB) | 1990-02-28 | — | — | EP | claimed |
| US-4867985-A | CONTROLLED RELEASE OF NON-STEROID ANTIINFLAMMATORY AGENTS | EUROCELTIQUE S.A. (LU) | 1989-09-19 | — | — | US | claimed |
| US-4753801-A | DRUGS, LOW WATER SOLUBILITY | ELI LILLY AND COMPANY (US) | 1988-06-28 | — | — | US | claimed |
| EP-0225005-A1 | Anti-inflammatory analgesic adhesive preparation | NITTO DENKO CORPORATION (JP) | 1987-06-10 | — | — | EP | claimed |
| EP-0221732-A2 | Sustained release tablets | ELI LILLY AND COMPANY (US) | 1987-05-13 | — | — | EP | claimed |
| US-4599359-A | POTENTIATION | Cooper, Stephen A. (US) | 1986-07-08 | — | — | US | claimed |
| EP-0174006-A2 | Antidiarrheal compositions and use thereof | Richardson-Vicks, Inc. (US) | 1986-03-12 | — | — | EP | claimed |
| WO-1984002273-A1 | ANALGESIC COMBINATIONS | SANDOZ AG (CH) | 1984-06-21 | — | — | WO | claimed |
| EP-0111456-A1 | Analgesic combinations | Cooper, Stephen A. Dr. (US) | 1984-06-20 | — | — | EP | claimed |